Effects of Schistosoma japonicum infection on OVA-induced allergic airway inflammation in mice

doi:10.12140/j.issn.1000-7423.2020.03.003

Abstract

Abstract:

Objective To investigate the effects of Schistosoma japonicum infection (21 days after infection) on ovalbumin (OVA)-induced allergic airway inflammation in mice. Methods Twenty female BALB/c mice were randomly divided into the healthy control group, infection group (INF), OVA group and infection+OVA group (INF+OVA), 5 mice each. Mice of the INF and INF+OVA groups were infected with 15 ± 2 S. japonicum cercariae by abdomen patches. Mice in the INF+OVA group and OVA group were intraperitoneally injected with 10 μg of OVA plus 2 mg of aluminum adjuvant to sensitize on day 21 and 35 after infection, and were given with aerosolized 1% OVA in PBS/mouse to challenge on day 42-46 after infection, whereas the mice of healthy control and infection group were challenged with PBS aerosol. Mice tail vein blood was collected on day 35 and 42 (sensitizing phase), and day 49 (challenging phase) for determination of serum IgE and OVA-specific IgE by ELISA. All mice were sacrificed on day 49 after infection, and lung and spleen tissues were collected. A part of the lung tissue was used to prepare pathological paraffin sections stained by hematoxylin eosin (HE) and periodic acid Schiff (PAS), to observe morphological changes in lung tissue vessel, inflammation peri-bronchi (inflammation score), and in hyperplasia of epithelial cells (hyperplasia score); the other part of lung and spleen tissues was used to prepare single cell suspensions for assaying proportions of CD4⁺CD25 ⁺Foxp3⁺ Tregs by flow cytometry. Results ELISA showed that the A₄₅₀ readings of serum IgE in the INF group on day 35, 42 and 49 were 0.291 ± 0.037, 0.388 ± 0.038 and 0.472 ± 0.053, respectively, which were significantly higher than those in healthy control (0.032 ± 0.018, 0.050 ± 0.016 and 0.043 ± 0.026) (all P < 0.01); the A₄₅₀ readings of IgE in the OVA group on day 35, 42 and 49 were 0.097 ± 0.065, 0.164 ± 0.083 and 0.274 ± 0.07, respectively, of which the readings on day 42 and 49 were significantly higher than those in healthy control (P < 0.01); the A₄₅₀ readings of IgE in the INF+OVA group on those days were 0.305 ± 0.054, 0.359 ± 0.037 and 0.454 ± 0.017, respectively, all significantly increased compared to the OVA group (P < 0.01). On day 35, 42 and 49 after infection, the A₄₅₀ values of OVA-specific IgE in the OVA group were 0.115 ± 0.021, 0.078 ± 0.014 and 0.245 ± 0.040, respectively, all significantly increased compared to the control group (0.081 ± 0.007, 0.054 ± 0.008, and 0.079 ± 0.008) (P < 0.01, 0.05, 0.05). However, those in the OVA+INF group (0.034 ± 0.009, 0.038 ± 0.016 and 0.203 ± 0.017) were all significantly lower than those in the OVA group (P < 0.01, 0.01, 0.05). Pathological examinations on day 49 after infection showed that the lung tissue inflammation scores on inflammatory cell infiltration peri-bronchi and blood vessels in the healthy control group, INF group, OVA group and INF+OVA group were 1.33 ± 0.47, 2.33 ± 0.27, 3.5 ± 0.19 and 2.87 ± 0.45, respectively, of them the inflammation score in the INF and OVA groups were both significantly increased, compared to the healthy control group (P < 0.01), while the score in the INF+OVA group was significantly reduced (P < 0.05). The hyperplasia scores in the healthy control group, INF group, OVA group and INF+OVA group were 0, 0, 2.12 ± 0.80 and 1.72 ± 0.55, respectively. The hyperplasia score in the OVA group was significantly increased compared to the healthy control group (P < 0.05), whereas the difference between the INF+OVA group and the OVA group was insignificant (P > 0.05). The assay results of flow cytometry on day 49 after infection showed that the proportions of Tregs in spleen and lung tissues were (16.24 ± 3.06)% and (10.19 ± 0.01)% in the healthy control group, (27.23 ± 5.62)% and (13.05 ± 1.10)% in the INF group, (17.22 ± 1.43)% and (12.34 ± 2.25)% in the OVA group, and (27.96 ± 1.80)% and (15.04 ± 1.41)% in the INF+OVA group, respectively. The lung and spleen Treg proportions in the INF group were significantly up-regulated compared to the healthy control group (both P < 0.05), while there was no significant difference between the OVA and control groups (P > 0.05). The spleen tissue Treg proportion showed a significant increase in the INF+OVA group compared to the OVA group (P < 0.01), while the lung Treg proportion showed no significant change (P > 0.05). Conclusion S. japonicum infection (21 days after infection) showed rsignificant regulatory effect on the OVA-induced allergic airway inflammation, reducing the serum OVA-specific IgE level at the sensitization and challenge phases of allergic inflammation, suppressing peri-bronchi and peri-vascular inflammatory cell infiltration induced by OVA, and leading to elevate Treg proportion in the spleen tissue.

Key words: Schistosoma japonicum, Allergic airway inflammation, Ovalbumin, Regulatory T cell, IgE

CLC Number:

R383.24

LI Zhi-dan, ZHANG Wei, WANG Xiao-ling, XU Bin, HU Wei. Effects of Schistosoma japonicum infection on OVA-induced allergic airway inflammation in mice[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2020, 38(3): 271-278.

Figures/Tables 4

Fig. 1

Fig. 2

Fig. 3

Fig. 4

References 40

[1]	Sears MR. Descriptive epidemiology of asthma[J]. Lancet, 1997, 350(Suppl 2): SⅡ1-SⅡ4.
[2]	Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypojournal[J]. Science, 2002,296(5567):490-494. pmid: 11964470
[3]	Smits HH, Yazdanbakhsh M. Chronic helminth infections modulate allergen-specific immune responses: protection against development of allergic disorders?[J]. Ann Med, 2007,39(6):428-439.
[4]	Romagnani S. Atopic allergy and other hypersensitivities interactions between genetic susceptibility, innocuous and/or microbial antigens and the immune system[J]. Curr Opin Immunol, 1997,9(6):773-775.
[5]	Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults[J]. Front Pediatr, 2019,7:246. pmid: 31275909
[6]	Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease[J]. Nat Rev Immunol, 2008,8(3):183-192.
[7]	Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma[J]. N Engl J Med, 1992,326(5):298-304. doi: 10.1056/NEJM199201303260504 pmid: 1530827
[8]	Holgate ST. Innate and adaptive immune responses in asthma[J]. Nat Med, 2012,18(5):673-683.
[9]	Haspeslagh E, Debeuf N, Hammad H, et al. Murine models of allergic asthma[J]. Methods Mol Biol, 2017,1559:121-136. pmid: 28063042
[10]	Strachan DP. Hay fever, hygiene, and household size[J]. BMJ, 1989,299(6710):1259-1260.
[11]	Umetsu DT. Early exposure to germs and the hygiene hypojournal[J]. Cell Res, 2012,22(8):1210-1211. pmid: 22525335
[12]	Wilson MS, Maizels RM. Regulation of allergy and autoimmunity in helminth infection[J]. Clin Rev Allergy Immunol, 2004,26(1):35-50.
[13]	Harnett W. Secretory products of helminth parasites as immunomodulators[J]. Mol Biochem Parasitol, 2014,195(2):130-136.
[14]	Mangan NE, van Rooijen N, McKenzie AN, et al. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness[J]. J Immunol, 2006,176(1):138-147.
[15]	Hübner MP, Stocker JT, Mitre E. Inhibition of type 1 diabetes in Filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of Foxp3⁺ regulatory T cells [J]. Immunology, 2009,127(4):512-522. doi: 10.1111/j.1365-2567.2008.02958.x pmid: 19016910
[16]	Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells[J]. Ann Neurol, 2008,64(2):187-199.
[17]	Peón AN, Ledesma-Soto Y, Olguín JE, et al. Helminth products potently modulate experimental autoimmune encephalomyelitis by downregulating neuroinflammation and promoting a suppressive microenvironment[J]. Mediators Inflamm, 2017,2017:8494572. doi: 10.1155/2017/8494572 pmid: 28744067
[18]	LoVerde PT. Schistosomiasis[J]. Adv Exp Med Biol, 2019,1154:45-70.
[19]	Ferragine CE, Walls CD, Davies SJ. Modulation of innate antigen-presenting cell function by pre-patent schistosome infection[J]. PLoS Negl Trop Dis, 2013,7(3):e2136. pmid: 23556020
[20]	Dunne DW, Cooke A. A worm’s eye view of the immune system: consequences for evolution of human autoimmune disease[J]. Nat Rev Immunol, 2005,5(5):420-426.
[21]	Mo HM, Lei JH, Jiang ZW, et al. Schistosoma japonicum infection modulates the development of allergen-induced airway inflammation in mice[J]. Parasitol Res, 2008,103(5):1183-1189. doi: 10.1007/s00436-008-1114-1
[22]	Cooke A, Tonks P, Jones FM, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice[J]. Parasite Immunol, 1999,21(4):169-176. pmid: 10320614
[23]	Liu Y, Ye Q, Liu YL, et al. Schistosoma japonicum attenuates dextran sodium sulfate-induced colitis in mice via reduction of endoplasmic reticulum stress[J]. World J Gastroenterol, 2017,23(31):5700-5712. doi: 10.3748/wjg.v23.i31.5700 pmid: 28883695
[24]	Jiang ZW, Mo HM, Wang L, et al. Suppression effect of different stage antigens of Schistosoma japonicum on airway inflammation in a murine model of asthma[J]. Chin J Parasitol Parasit Dis, 2008,26(6):428-431, 437.
	( 蒋自卫, 莫红梅, 王磊, 等. 日本血吸虫不同阶段抗原免疫抑制过敏性哮喘小鼠气道炎症的实验观察[J]. 中国寄生虫学与寄生虫病杂志, 2008,26(6):428-431, 437.)
[25]	Li J, Yang XZ, Liu JX, et al. Influence of Schistosoma japonicum infection on OVA-induced allergic reaction of mice[J]. Chin J Zoonoses, 2008,24(3):233-236. (in Chinese)
	( 李健, 杨秀珍, 刘金霞, 等. 日本血吸虫感染对OVA诱导的小鼠过敏反应的影响[J]. 中国人兽共患病学报, 2008,24(3):233-236.)
[26]	Liu JX, Yang XZ, Liu PM, et al. Study on the effect of Schistosoma japonicum infection on allergic asthma[J]. J Pathog Biol, 2008,3(4):272-275. (in Chinese)
	( 刘金霞, 杨秀珍, 刘佩梅, 等. 日本血吸虫感染对过敏性哮喘影响的实验研究[J]. 中国病原生物学杂志, 2008,3(4):272-275.)
[27]	Smits HH, Hammad H, van Nimwegen M, et al. Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection[J]. J Allergy Clin Immunol, 2007,120(4):932-940. doi: 10.1016/j.jaci.2007.06.009 pmid: 17689595
[28]	Maruthamuthu V, Ramar M, Henry LJ, et al. Myxopyrum serratulum ameliorates the airway inflammation in LPS stimulated RAW 264.7 murine macrophages and OVA induced murine model of allergic asthma[J]. J Ethnopharmacol, 2019: 112369.
[29]	Underwood S, Foster M, Raeburn D, et al. Time-course of antigen-induced airway inflammation in the Guinea-pig and its relationship to airway hyperresponsiveness[J]. Eur Respir J, 1995,8(12):2104-2113. doi: 10.1183/109031936.95.08122104 pmid: 8666107
[30]	Hamid Q, Tulic M. Immunobiology of asthma[J]. Annu Rev Physiol, 2009,71:489-507. doi: 10.1146/annurev.physiol.010908.163200 pmid: 19575684
[31]	Keskin O, Keskin M, Kucukosmanoglu E, et al. Exhaled RANTES and interleukin 4 levels after exercise challenge in children with asthma[J]. Ann Allergy Asthma Immunol, 2012,109(5):303-308. doi: 10.1016/j.anai.2012.08.009 pmid: 23062383
[32]	Gould HJ, Sutton BJ. IgE in allergy and asthma today[J]. Nat Rev Immunol, 2008,8(3):205-217. doi: 10.1038/nri2273 pmid: 18301424
[33]	Martin JG, Suzuki M, Ramos-Barbón D, et al. T cell cytokines: animal models[J]. Paediatr Respir Rev, 2004,5(Suppl A):S47-S51. doi: 10.1016/S1526-0542(04)90010-3
[34]	Maslan J, Mims JW. What is asthma? Pathophysiology, demographics, and health care costs[J]. Otolaryngol Clin North Am, 2014,47(1):13-22. doi: 10.1016/j.otc.2013.09.010 pmid: 24286675
[35]	Houssen ME, Ragab A, Mesbah A, et al. Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthma[J]. Clin Biochem, 2010,43(10/11):887-890.
[36]	Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4⁺CD25⁺ regulatory T cells [J]. Nat Immunol, 2003,4(4):330-336. doi: 10.1038/ni904 pmid: 12612578
[37]	Turner JD, Jackson JA, Faulkner H, et al. Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness[J]. J Infect Dis, 2008,197(8):1204-1212. doi: 10.1086/586717 pmid: 18462167
[38]	Layland LE, Straubinger K, Ritter M, et al. Schistosoma mansoni-mediated suppression of allergic airway inflammation requires patency and Foxp3⁺ Treg cells [J]. PLoS Negl Trop Dis, 2013,7(8):e2379. doi: 10.1371/journal.pntd.0002379 pmid: 23967364
[39]	Zhu YJ, Yang XZ, Liu X, et al. A study of the effects of Schistosoma japonicum soluble egg antigen on CD4⁺CD25⁺ regulatory T cells in patients with asthma[J]. J Pathog Biol, 2011, 6(9): 663-665, 693, 721. (in Chinese)
	( 朱云娟, 杨秀珍, 刘霞, 等. CD4⁺CD25⁺调节性T细胞在血吸虫可溶性虫卵抗原影响哮喘中的作用研究[J]. 中国病原生物学杂志, 2011, 6(9): 663-665, 693, 721.)
[40]	Obieglo K, Schuijs MJ, Ozir-Fazalalikhan A, et al. Isolated Schistosoma mansoni eggs prevent allergic airway inflammation[J]. Parasite Immunol, 2018,40:e12579. doi: 10.1111/pim.12579 pmid: 30107039